Qdenga 유럽 연합 - 이탈리아어 - EMA (European Medicines Agency)

qdenga

takeda gmbh - dengue virus, serotype 2, expressing dengue virus, serotype 1, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 3, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 4, surface proteins, live, attenuated, dengue virus, serotype 2, live, attenuated - dengue - vaccini - qdenga is indicated for the prevention of dengue disease in individuals from 4 years of age. the use of qdenga should be in accordance with official recommendations.

PERNEXIN 이탈리아 - 이탈리아어 - AIFA (Agenzia Italiana del Farmaco)

pernexin

bayer s.p.a. - ferro trivalente, preparati orali - ferro trivalente, preparati orali

FERPLEX FOL 이탈리아 - 이탈리아어 - AIFA (Agenzia Italiana del Farmaco)

ferplex fol

italfarmaco s.p.a. - ferro trivalente, preparati orali - ferro trivalente, preparati orali

Jevtana 60 mg/1.5 ml solution à diluer et solvant pour solution pour perfusion 스위스 - 이탈리아어 - Swissmedic (Swiss Agency for Therapeutic Products)

jevtana 60 mg/1.5 ml solution à diluer et solvant pour solution pour perfusion

sanofi-aventis (suisse) sa - cabazitaxelum - solution à diluer et solvant pour solution pour perfusion - cabazitaxelum 60 mg ut cabazitaxeli acetoni solvatum, polysorbatum 80, acidum citricum monohydricum, pro vitro. solvens: ethanolum 96 per centum 573.3 mg, aqua ad iniectabile ad solutionem pro 4.5 ml. - citostatici - synthetika

Cabazitaxel Accord 60 mg/3 ml Concentrato per soluzione per Infusione 스위스 - 이탈리아어 - Swissmedic (Swiss Agency for Therapeutic Products)

cabazitaxel accord 60 mg/3 ml concentrato per soluzione per infusione

accord healthcare ag - cabazitaxelum - concentrato per soluzione per infusione - cabazitaxelum 60 mg, ethanolum anhydricum 1185 mg, polysorbatum 80, acidum citricum q.s. ad ph, ad solutionem pro 3 ml. - farmaco - synthetika

Vegzelma 유럽 연합 - 이탈리아어 - EMA (European Medicines Agency)

vegzelma

celltrion healthcare hungary kft. - bevacizumab - colorectal neoplasms; breast neoplasms; ovarian neoplasms; fallopian tube neoplasms; peritoneal neoplasms; carcinoma, non-small-cell lung; carcinoma, renal cell; uterine cervical neoplasms - agenti antineoplastici - vegzelma in combination with fluoropyrimidine based chemotherapy is indicated for treatment of adult patients with metastatic carcinoma of the colon or rectum. vegzelma in combination with paclitaxel is indicated for first line treatment of adult patients with metastatic breast cancer. per ulteriori informazioni sullo stato del recettore del fattore di crescita epidermico umano 2 (her2), fare riferimento alla sezione 5. vegzelma in combination with capecitabine is indicated for first line treatment of adult patients with metastatic breast cancer in whom treatment with other chemotherapy options including taxanes or anthracyclines is not considered appropriate. patients who have received taxane and anthracycline containing regimens in the adjuvant setting within the last 12 months should be excluded from treatment with vegzelma in combination with capecitabine. per ulteriori informazioni sullo stato her2, fare riferimento alla sezione 5. vegzelma, in addition to platinum based chemotherapy, is indicated for first line treatment of adult patients with unresectable advanced, metastatic or recurrent non small cell lung cancer (nsclc) other than predominantly squamous cell histology. vegzelma, in combination with erlotinib, is indicated for first line treatment of adult patients with unresectable advanced, metastatic or recurrent nsclc with epidermal growth factor receptor (egfr) activating mutations (see section 5. vegzelma, in combination with interferon alfa 2a is indicated for first line treatment of adult patients with advanced and/or metastatic renal cell cancer. vegzelma, in combination with carboplatin and paclitaxel is indicated for the front line treatment of adult patients with advanced (international federation of gynecology and obstetrics (figo) stages iii b, iii c and iv) epithelial ovarian, fallopian tube, or primary peritoneal cancer (see section 5. vegzelma, in combination with carboplatin and gemcitabine or in combination with carboplatin and paclitaxel, is indicated for treatment of adult patients with first recurrence of platinum sensitive epithelial ovarian, fallopian tube or primary peritoneal cancer who have not received prior therapy with bevacizumab or other vascular endothelial growth factor (vegf) inhibitors or vegf receptor–targeted agents. vegzelma in combination with paclitaxel, topotecan, or pegylated liposomal doxorubicin is indicated for the treatment of adult patients with platinum resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who received no more than two prior chemotherapy regimens and who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor–targeted agents (see section 5. vegzelma, in combination with paclitaxel and cisplatin or, alternatively, paclitaxel and topotecan in patients who cannot receive platinum therapy, is indicated for the treatment of adult patients with persistent, recurrent, or metastatic carcinoma of the cervix (see section 5.

Cabazitaxel-Teva 60 mg/6 ml Concentrato per soluzione per Infusione 스위스 - 이탈리아어 - Swissmedic (Swiss Agency for Therapeutic Products)

cabazitaxel-teva 60 mg/6 ml concentrato per soluzione per infusione

teva pharma ag - cabazitaxelum - concentrato per soluzione per infusione - cabazitaxelum 60 mg ut cabazitaxeli isopropanoli solvatum, acidum citricum, ethanolum anhydricum 1092 mg, polysorbatum 80, macrogolum 400, ad solutionem pro 6 ml. - farmaco - synthetika

Innovax-ND-ILT 유럽 연합 - 이탈리아어 - EMA (European Medicines Agency)

innovax-nd-ilt

intervet international b.v. - cell-associated live recombinant turkey herpesvirus (strain hvt/ndv/ilt) expressing the fusion protein of newcastle disease virus and the glycoproteins gd and gi of infectious laryngotracheitis virus - immunologici per aves - embryonated chicken eggs; chicken - for active immunisation of one-day-old chicks or embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to reduce mortality, clinical signs and lesions caused by avian infectious laryngotracheitis (ilt) virus and marek’s disease (md) virus.

Certosan 스위스 - 이탈리아어 - OFAG-BLW (Bundesamt für Landwirtschaft)

certosan

sintagro ag - proteine - wppolvere bagnabile - 99 % [di farina di sangue]; - repellente antiselvaggina ;

RABISIN 이탈리아 - 이탈리아어 - Ministero della Salute

rabisin

boehringer ingelheim animal health italia s.p.a - glicoproteine del virus della rabbia - glicoproteine del virus della rabbia - 1 ui - rabies virus